Bo Ryoung Park

515 total citations
23 papers, 346 citations indexed

About

Bo Ryoung Park is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Bo Ryoung Park has authored 23 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 13 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Bo Ryoung Park's work include Influenza Virus Research Studies (18 papers), Respiratory viral infections research (13 papers) and Immune Cell Function and Interaction (11 papers). Bo Ryoung Park is often cited by papers focused on Influenza Virus Research Studies (18 papers), Respiratory viral infections research (13 papers) and Immune Cell Function and Interaction (11 papers). Bo Ryoung Park collaborates with scholars based in United States, South Korea and Canada. Bo Ryoung Park's co-authors include Minsu Kim, Le Dai, Sukanya Iyer, Sang‐Moo Kang, Ki‐Hye Kim, Subbiah Jeeva, Waqas Chaudhry, Bao‐Zhong Wang, Chong Hyun Shin and Min‐Chul Kim and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and PLoS ONE.

In The Last Decade

Bo Ryoung Park

23 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Ryoung Park United States 10 157 123 96 85 76 23 346
Emily A. Snavely United States 6 58 0.4× 126 1.0× 33 0.3× 41 0.5× 65 0.9× 14 289
Preeti Thakur India 10 69 0.4× 213 1.7× 92 1.0× 22 0.3× 142 1.9× 23 393
Elena Del Tordello Italy 8 202 1.3× 123 1.0× 51 0.5× 70 0.8× 50 0.7× 9 378
Sriram Varahan United States 9 26 0.2× 138 1.1× 42 0.4× 43 0.5× 92 1.2× 17 296
Zachary N. Phillips Australia 9 58 0.4× 84 0.7× 34 0.4× 24 0.3× 57 0.8× 14 216
Katherine S. Xue United States 11 158 1.0× 233 1.9× 150 1.6× 51 0.6× 113 1.5× 14 535
Christine L. Weingart United States 11 181 1.2× 198 1.6× 85 0.9× 52 0.6× 49 0.6× 13 504
Elizabeth S. C. P. Williams United States 10 32 0.2× 70 0.6× 53 0.6× 36 0.4× 96 1.3× 17 264
Olga L. Voronina Russia 11 52 0.3× 151 1.2× 34 0.4× 19 0.2× 60 0.8× 65 363
Madhusudan Rajendran United States 9 341 2.2× 117 1.0× 55 0.6× 148 1.7× 108 1.4× 19 466

Countries citing papers authored by Bo Ryoung Park

Since Specialization
Citations

This map shows the geographic impact of Bo Ryoung Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ryoung Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ryoung Park more than expected).

Fields of papers citing papers by Bo Ryoung Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ryoung Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ryoung Park. The network helps show where Bo Ryoung Park may publish in the future.

Co-authorship network of co-authors of Bo Ryoung Park

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ryoung Park. A scholar is included among the top collaborators of Bo Ryoung Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ryoung Park. Bo Ryoung Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ki‐Hye, Rong Liu, Chong Hyun Shin, et al.. (2025). Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered. The Journal of Immunology. 214(1). 104–114. 3 indexed citations
2.
3.
Liu, Rong, Janhavi P. Natekar, Ki‐Hye Kim, et al.. (2024). Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants. Vaccines. 12(4). 362–362. 3 indexed citations
4.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2023). Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination. Vaccines. 11(7). 1209–1209. 6 indexed citations
5.
Park, Bo Ryoung, Ramireddy Bommireddy, Ki‐Hye Kim, et al.. (2023). Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice. Immunity & Ageing. 20(1). 20–20. 6 indexed citations
6.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2022). Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination. Vaccines. 10(9). 1383–1383. 5 indexed citations
7.
Kim, Ki‐Hye, Zhuo Li, Subbiah Jeeva, et al.. (2022). Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle. PLoS Pathogens. 18(8). e1010755–e1010755. 26 indexed citations
8.
Jeeva, Subbiah, Ki‐Hye Kim, Chong Hyun Shin, et al.. (2022). A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine. npj Vaccines. 7(1). 68–68. 23 indexed citations
9.
Kim, Ki‐Hye, Chong Hyun Shin, Bo Ryoung Park, et al.. (2022). Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses. Molecular Therapy — Methods & Clinical Development. 26. 38–51. 5 indexed citations
10.
Jeeva, Subbiah, Ki‐Hye Kim, Bo Ryoung Park, et al.. (2022). Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses. Virology. 574. 37–46. 2 indexed citations
11.
Park, Bo Ryoung, Subbiah Jeeva, Ki‐Hye Kim, et al.. (2021). Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes. Virology. 566. 143–152. 3 indexed citations
12.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2021). Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines. 9(4). 316–316. 11 indexed citations
13.
Park, Bo Ryoung, Ki‐Hye Kim, Min‐Chul Kim, et al.. (2021). Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin. Scientific Reports. 11(1). 4151–4151. 17 indexed citations
14.
Kim, Ki‐Hye, Subbiah Jeeva, Bo Ryoung Park, et al.. (2021). Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice. Antiviral Research. 197. 105229–105229. 10 indexed citations
15.
16.
17.
Kim, Ki‐Hye, Bo Ryoung Park, Yu‐Jin Jung, et al.. (2020). Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes. Vaccines. 8(4). 648–648. 10 indexed citations
18.
Kang, Hae‐Ji, Ki‐Back Chu, Dong‐Hun Lee, et al.. (2019). Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs. PLoS ONE. 14(6). e0216871–e0216871. 33 indexed citations
19.
Park, Bo Ryoung, et al.. (2018). Antibiotic-induced population fluctuations and stochastic clearance of bacteria. eLife. 7. 68 indexed citations
20.
Kim, Jee-Sang, et al.. (2014). Membrane Process Using Polysulfone Hollow Fiber Membranes for Vehicle Fuel Production from Bio-Methane Mixture. Membrane Journal. 24(3). 213–222. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily A. Snavely Breakdown of academic impact, for papers by Preeti Thakur Breakdown of academic impact, for papers by Elena Del Tordello Breakdown of academic impact, for papers by Sriram Varahan Breakdown of academic impact, for papers by Zachary N. Phillips Breakdown of academic impact, for papers by Katherine S. Xue Breakdown of academic impact, for papers by Christine L. Weingart Breakdown of academic impact, for papers by Elizabeth S. C. P. Williams Breakdown of academic impact, for papers by Olga L. Voronina Breakdown of academic impact, for papers by Madhusudan Rajendran
Rankless by CCL
2026